After our fecal metabonomic study of colorectal cancer (CRC) patients recently published in Oncotarget , we profiled urine metabolites from the same group of CRC patients, 40 age-matched healthy controls (HC), 18 esophageal cancers (EC), using proton nuclear magnetic resonance spectroscopy in conjunction with a multivariate statistics technique. OPLS-DA revealed that each stage of CRC could be clearly distinguished from HC and EC based on their different metabolomic profiles. These altered urine metabolites of CRC patients from HC potentially involved in the disrupted common pathways, and the different metabolites in CRC compare to EC indicated the special of the CRC.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords